Global Amino Acid Metabolism Disorders Treatment Market Report, History and Forecast 2018-2034, Breakdown Data by Companies, Key Regions, Types and Application
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global Amino Acid Metabolism Disorders Treatment Market Report, History and Forecast 2018-2034, Breakdown Data by Companies, Key Regions, Types and Application
Amino Acid Metabolism Disorders Treatment report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Amino Acid Metabolism Disorders Treatment market is projected to reach US$ 789.2 million in 2034, increasing from US$ 547 million in 2022, with the CAGR of 5.3% during the period of 2024 to 2034. Demand from Phenylketonuria and Maple Syrup Urine Disease are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Amino Acid Metabolism Disorders Treatment industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, Amino Acid Metabolism Disorders Treatment key companies include GlaxoSmithKline, Pfizer, AMINO, Merck, Recordati, Koninklijke, Sanofi, Shine Star (Hubei) Biological Engineering and Kyowa Hakko Kirin, etc. GlaxoSmithKline, Pfizer, AMINO are top 3 players and held % share in total in 2022.
Amino Acid Metabolism Disorders Treatment can be divided into Arginine, Folic Acid, Vitamin B6 & B12 and Thiamine, etc. Arginine is the mainstream product in the market, accounting for % share globally in 2022.
Amino Acid Metabolism Disorders Treatment is widely used in various fields, such as Phenylketonuria, Maple Syrup Urine Disease, Argininosuccinic Acidemia and Citrullinemia, etc. Phenylketonuria provides greatest supports to the Amino Acid Metabolism Disorders Treatment industry development. In 2022, global % share of Amino Acid Metabolism Disorders Treatment went into Phenylketonuria filed.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Amino Acid Metabolism Disorders Treatment market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Companies, Type, Application and Regions Listed in the Report
GlaxoSmithKline
Pfizer
AMINO
Merck
Recordati
Koninklijke
Sanofi
Shine Star (Hubei) Biological Engineering
Kyowa Hakko Kirin
Segment by Type
Arginine
Folic Acid
Vitamin B6 & B12
Thiamine
Vitamin D
Betaine
Carglumic Acid
Sapropterin Dihydrochloride
Others
Phenylketonuria
Maple Syrup Urine Disease
Argininosuccinic Acidemia
Citrullinemia
Homocystinuria
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Latin America
Mexico
Brazil
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Amino Acid Metabolism Disorders Treatment market further
Chapter 1Global and regional market size and CAGR for the history and forecast period (2018-2024, 2024-2034).
Chapter 2Product Types and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 3Product Application and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 4Company Competition Status, Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5Companies’ Outline, covering company’s basic information, Amino Acid Metabolism Disorders Treatment introduction, etc. Amino Acid Metabolism Disorders Treatment Revenue and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 6 to 10Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa by revenue.
Chapter 11Market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry.
Chapter 12QYResearch’s Conclusions of Amino Acid Metabolism Disorders Treatment market based on comprehensive survey.
Chapter 13Methodology and Data Sources adopted by QYResearch.
North America, Europe and Asia Pacific are the key regions for Amino Acid Metabolism Disorders Treatment industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, Amino Acid Metabolism Disorders Treatment key companies include GlaxoSmithKline, Pfizer, AMINO, Merck, Recordati, Koninklijke, Sanofi, Shine Star (Hubei) Biological Engineering and Kyowa Hakko Kirin, etc. GlaxoSmithKline, Pfizer, AMINO are top 3 players and held % share in total in 2022.
Amino Acid Metabolism Disorders Treatment can be divided into Arginine, Folic Acid, Vitamin B6 & B12 and Thiamine, etc. Arginine is the mainstream product in the market, accounting for % share globally in 2022.
Amino Acid Metabolism Disorders Treatment is widely used in various fields, such as Phenylketonuria, Maple Syrup Urine Disease, Argininosuccinic Acidemia and Citrullinemia, etc. Phenylketonuria provides greatest supports to the Amino Acid Metabolism Disorders Treatment industry development. In 2022, global % share of Amino Acid Metabolism Disorders Treatment went into Phenylketonuria filed.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Amino Acid Metabolism Disorders Treatment market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Companies, Type, Application and Regions Listed in the Report
By Company
GlaxoSmithKline
Pfizer
AMINO
Merck
Recordati
Koninklijke
Sanofi
Shine Star (Hubei) Biological Engineering
Kyowa Hakko Kirin
Segment by Type
Arginine
Folic Acid
Vitamin B6 & B12
Thiamine
Vitamin D
Betaine
Carglumic Acid
Sapropterin Dihydrochloride
Others
Segment by Application
Phenylketonuria
Maple Syrup Urine Disease
Argininosuccinic Acidemia
Citrullinemia
Homocystinuria
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Latin America
Mexico
Brazil
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Amino Acid Metabolism Disorders Treatment market further
Chapter 1Global and regional market size and CAGR for the history and forecast period (2018-2024, 2024-2034).
Chapter 2Product Types and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 3Product Application and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 4Company Competition Status, Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5Companies’ Outline, covering company’s basic information, Amino Acid Metabolism Disorders Treatment introduction, etc. Amino Acid Metabolism Disorders Treatment Revenue and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 6 to 10Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa by revenue.
Chapter 11Market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry.
Chapter 12QYResearch’s Conclusions of Amino Acid Metabolism Disorders Treatment market based on comprehensive survey.
Chapter 13Methodology and Data Sources adopted by QYResearch.